Navigation Links
New York Orthopedics Clinical Trial Recruitment Re-opens

Mt. Kisco, New York (PRWEB) May 14, 2013

The Clinical Trials Program at Northern Westchester Hospital is pleased to announce an extended enrollment period for a total knee replacement pain management clinical trial.

Also known as “The PACIRA Trial,” this study seeks to evaluate the safety, efficacy and pharmacokinetics of a single injection femoral nerve block with liposome bupivacaine for post-operative pain for patients undergoing a total knee replacement.

Total knee arthroplasty, or knee replacement surgery, is one of the most common joint replacement procedures and is performed on over 600,000 people worldwide each year.

The PACIRA Trial is a multicenter, randomized, double-blind, parallel-group, placebo-controlled, dose-ranging study to evaluate the safety, efficacy and pharmacokinetics of a single injection femoral nerve block with liposome bupivacaine for post-operative pain for patients undergoing a total knee arthroplasty.

Enrollment for the PACIRA Trial will end October 2013.

There are several eligibility criteria for the Pacira trial; including the following:

  •          Age 18+ undergoing a primary unilateral total knee arthroplasty under general or spinal anesthesia
  •     Patient must weigh more than 110 lbs
  •     No previous participation in liposome bupivacain studies

Dr. Stuart Styles, Co-Director of Joint Replacement Surgery, Orthopedic and Spine Institute is the Principal Investigator for the PACIRA Trial along with Co-Investigator Dr. Christie Sasso.

The Clinical Trial Program at Northern Westchester Hospital is actively recruiting patients for this clinical trial and others. For more information about joining the study, please call 914-666-1366 or contact us online today.

About Northern Westchester Hospital

Northern Westchester Hospital(NWH) provides quality, patient-centered care that is close to home through a unique combination of medical expertise, leading-edge technology, and a commitment to humanity. Over 750 highly-skilled physicians, state-of-the-art technology and professional staff of caregivers are all in place to ensure that you and your family receive treatment in a caring, respectful and nurturing environment.

NWH has established extensive internal quality measurements that surpass the standards defined by the Centers for Medicare & Medicaid Services (CMS) and the Hospital Quality Alliance (HQA). Our high-quality standards help to ensure that the treatment you receive at NWH is among the best in the nation. For a complete list of our services, please visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Valley Orthopedics Welcomes New Orthopedic Surgeon Specializing in Hip Procedures
2. Fox Valley Orthopedics Surgeon Dr. Craig Popp Says New Minimally Invasive Herniated Disc Surgery Less Painful
3. Women's Choice Award Honors Orthopedics Hospitals Most Recommended by Women
4. Citizens Medical Center Earns the Women’s Choice Award for Excellence in Orthopedics
5. Catawba Valley Medical Center Earns the Women’s Choice Award for Excellence in Orthopedics
6. First targeted nanomedicine to enter human clinical studies
7. Clinical insight improves treatment with new lung cancer drug
8. Clinical news alert from the American Academy of Orthopaedic Surgeons
9. NYU Langone experts present research, clinical advances at neurosurgeons meeting
10. Kroenke honored for outstanding contributions in clinical research training
11. Awards celebrate clinical research that can improve health and alleviate suffering
Post Your Comments:
(Date:11/30/2015)... ... ... While powdered supplements and drinks can reduce food preparation time, locating the ... has found an easy to keep track of the scoop. , He developed a ... a canister or other container handy and readily accessible. As such, it prevents the ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... announced at the Radiology Society of North America (RSNA) annual meeting, being held ... 60% growth from 2014. Throughout 2015, the company has completed installations for ...
(Date:11/30/2015)... ... November 30, 2015 , ... Volpara Solutions ... density assessment and enterprise analytics solutions, here at the 101st Annual Radiological ... booth #2377). Volpara’s quantitative breast imaging tools enable personalized measurements of volumetric ...
(Date:11/30/2015)... ... ... It’s inevitable that everyone will experience death in his or her lifetime. Whether ... among us. It is your perspective, however, that determines how you view death in ... Sky understands that she may see death more frequently than most. As she was ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... the speakers for “Value-Based Payer-Provider Partnerships: Three Case Studies,” an upcoming Dec. ... care arrangements: Essentia Health and UCare, MissionPoint Health Partners, and Intel Corp. ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Nov. 30, 2015  Novartis will demonstrate the strength ... th American Society of Hematology (ASH) Annual Meeting. ... as well as supportive care, including key findings in ... cell therapies. The ASH Annual Meeting will be held ... Novartis Oncology . "We will be presenting ...
(Date:11/30/2015)... BOSTON , November 30, 2015 ... medicines directed at up to 10 G protein-coupled receptor ... PFE ) to research and develop potential new medicines ... targets across multiple therapeutic areas. --> Heptares ... development company and wholly-owned subsidiary of Sosei Group Corporation ...
(Date:11/30/2015)... TEL AVIV, Israel , November 30, 2015 /PRNewswire/ ... EMITF ) ("Elbit" or the "Company") announced today that it ... Ministry of Food and Drug Safety (MFDS) has approved ... behavioral disorders. --> --> ... presenting a non-invasive treatment alternative that combines two technologies: ...
Breaking Medicine Technology: